0.25 CME Credits. In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials. First, we dive into the recent charges brought by the US Department of Justice against executives at Done, a California-based telehealth company, for alleged healthcare fraud. Done is accused of prescribing over 40 million Adderall pills to patients without proper evaluation, raising concerns about the balance between increasing mental healthcare access and responsible prescribing practices.

Learn what therapies work for PTSD, what goes on in session, and how to prevent PTSD when your patient calls after a trauma.

Dr. Kramer examines how certain antidepressants can alter personality traits, while also exploring the ethical concerns and long-term effects of these changes.

Listen to the full text of the issue read aloud by Gregory Malzberg, MD. Gepirone (Exxua) gets a critical review. The Neuroscience-Based Nomenclature reclassifies psych meds, and Peter Kramer reflects on whether SSRIs change personality 30 years after his classic Listening to Prozac.